EMN Perspective is a scientific educational initiative developed for healthcare professionals involved in the management of multiple myeloma. The programme combines live and on-demand webinars with a guided digital platform featuring an integrated AI tool, designed to support rapid consultation of curated scientific content.
Educational Committee – Program coordinators:
Annamaria Brioli
Germany
Maria Gavriatopoulou
Greece
Adrian Mosquera
Spain
Ioannis Ntanasis-Stathopoulos
Greece
Jakub Radocha
Czech Republic
Claudia Stege
Netherlands
EMN Executives
What's inside
Patients with Newly Diagnosed Multiple Myeloma
02 November 02:30pm CET
Diagnostic and therapeutic approach in patients with newly diagnosed Multiple Myeloma
- Chair: F. Gay
- 02 November, 2:30-4:00 pm CET
- 90 min
Topics covered:
- What is the standard / best choice? – F. Gay
- Maintenance – what is the best duration? – E. Zamagni
- Future perspective frontline – E. Terpos
- Challenging case – A. Brioli
- Concluding discussion
Patients with Relapse/Refractory Multiple Myeloma
Management of early and late relapse, therapeutic sequencing strategies
- Chair: M.V. Mateos (TBC)
- July 2026
- 90 min
Topics covered:
- Early relapse – M.V. Mateos
- Later relapse – H. Einsele
- Sequencing – N. van de Donk
- Challenging case – M. Talarico
- Concluding discussion
Adverse Events: Recognition, management, and coordination of care
24 November 16:30pm CET
Recognition and management of adverse events
- Chair: M. Gavriatopoulou
- 24 November 16:30pm CET
- 90 min
Topics covered:
- Neurotoxicity – L. Rasche
- Ophthalmologic – M. Gavriatopoulou
- Skin, nails, mouth – I.Ntanasis-Stathopoulos
- Immune system/infections – J. Radocha
- Challenging case – L. Bertamini
- Concluding discussion
Special scenarios
1 December 16:30pm CET
Complex clinical scenarios: EMD, PPCL, and high-risk situations
- Chair: M. Beksac (TBC)
- 1 December 16:30pm CET
- 90 min
Topics covered:
- Extramedullary disease (EMD) – M. Beksac
- Primary plasma cell leukemia (PPCL) – P. Musto
- Functional high-risk disease – R. Mina
- Challenging Case – L. Leypoldt
- Concluding discussion
Future innovations and AI
21 December 15:30pm CET
Artificial intelligence in hemato-oncology: clinical applications and regulatory perspectives
- Chair: A. Mosquera and J.N. Eckardt
- December 2026
- 90 min
Topics covered:
- Generative AI for clinicians (basic principles, capabilities and limitations, hallucinations, and how to interact safely and critically with a chatbot-based tool) – A. Mosquera
- Applied AI in hemato-oncology (AI in medical imaging and image-derived risk biomarkers) – J.N. Eckardt
- Relevant EMN projects in AI for Multiple Myeloma – A. Mosquera
- Regulatory and clinical-trial perspectives on AI applications in Europe – J.N. Eckardt
- Concluding discussion